- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Industry-Standard Ultratech AP300 Enables Cost Effective Lithography Solution for Packaging Foundries
Ultratech, Inc.(Nasdaq: UTEK), a leading supplier of lithography and laser-processing
systems used to manufacture semiconductors and nanotechnology devices,
today announced that Chipbond Technology Corp. (Hsin-chu, Taiwan), one of
the world's largest merchant gold-bump foundries, has ordered Ultratech's
Unity AP300 advanced-packaging (AP) lithography tool. Building on the
successful implementation of the Unity platform for gold bump, Chipbond
will employ the Unity AP300 to support its migration into 300mm solder-bump
processing. The AP300 is built on Ultratech's customizable Unity
Platform(TM), which provides the best cost-of-ownership (CoO), operational
flexibility and technology extendibility essential for foundries to
maintain their competitive technology roadmaps.
According to Jan Vardaman, president and founder of TechSearch
International, Inc., the 300mm bump market, with a compound annual growth
rate of more than 42 percent, is the fastest-growing segment of the flip
chip market. As a result, many of the new bump line installations for
solder and wafer-level packaging will be 300mm lines.
"This order reinforces Ultratech's AP300 system as the industry
standard for the growing foundry market, where requirements are primarily
driven by economic factors," said Manish Ranjan, director, product
marketing at Ultratech. "We greatly value our strong relationship with
Chipbond and look forward to supporting the company's technology roadmap
and migration to 300mm solder-bump processing."
About Ultratech, Inc.
Ultratech, Inc. (Nasdaq: UTEK) designs, manufactures
and markets photolithography equipment used worldwide in the fabrication of
semiconductor and nanotechnology devices, and has expanded its technology
scope in pioneering laser processing technology for IC manufacturing.
Founded in 1979, Ultratech is a market leader in gold and solder bump
lithography. Its products are designed to substantially reduce the cost of
ownership for manufacturers in the electronics industry. The company's home
page on the World Wide Web is located at http://www.ultratech.com.
NOTE: Unity Platform is a trademark of Ultratech, Inc.
About Chipbond: Founded in 1997 by semiconductor industry veterans,
Chipbond Technology was the early pioneer in providing wafer-bumping
services to Taiwan, and has been growing at a steady pace to become a
technology leader in the industry. Located in Taiwan's Hsin-chu
Science-Based Industrial Park. Both gold bumping and solder bumping
services are available for customers' advanced packaging technology
requirements. In addition to wafer bumping, Chipbond is also providing tape
carrier packaging (TPC) and chip on glass (COG) turnkey solutions
especially targeted toward a range of display driver ICs. More information
is available at http://www.chipbond.com.tw .
Certain of the statements contained herein, which are not historical
facts and which can generally be identified by words such as "anticipates,"
"expects," "intends," "will," "could," "believes," "estimates," "continue,"
and similar expressions, are forward-looking statements under Section 27A
of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, that involve risks and
uncertainties, such as risks related to our dependence on new product
introductions and market acceptance of new products and enhanced versions
of our existing products; lengthy sales cycles, including the timing of
system installations and acceptances; lengthy and costly development cycles
for laser-processing and lithography technologies and applications;
integration, development and associated expenses of the laser processing
operation; delays, deferrals and cancellations of orders by customers;
cyclicality in the semiconductor and nanotechnology industries; pricing
pressures and product discounts; high degree of industry competition;
intellectual property matters; expiration of licensing arrangements, and
the resulting adverse impact on our licensing revenues; changes to
financial accounting standards; changes in pricing by us, our competitors
or suppliers; customer concentration; international sales; timing of new
product announcements and releases by us or our competitors; ability to
volume produce systems and meet customer requirements; sole or limited
sources of supply; ability and resulting costs to attract or retain
sufficient personnel to achieve our targets for a particular period;
dilutive effect of employee stock option grants on net income per share,
which is largely dependent upon us achieving and maintaining profitability
and the market price of our stock; mix of products sold; rapid
technological change and the importance of timely product introductions;
outcome of litigation; changes in accounting policies or interpretations of
such policies; manufacturing variances and production levels; timing and
degree of success of technologies licensed to outside parties; product
concentration and lack of product revenue diversification; inventory
obsolescence; asset impairment; effects of certain anti-takeover
provisions; future acquisitions; volatility of stock price; foreign
government regulations and restrictions, the political restrictions in
Taiwan regarding offshore investments and the exporting of sensitive
technologies and jobs to certain countries; business interruptions due to
natural disasters or utility failures; environmental regulations; and any
adverse effects of terrorist attacks in the United States or elsewhere, or
government responses thereto, or military actions in Iraq, Afghanistan and
elsewhere, on the economy, in general, or on our business in particular.
Such risks and uncertainties are described in Ultratech's SEC reports
including its Annual Report on Form 10-K filed for the year ended December
31, 2006 and Quarterly Report on Form 10-Q for the quarter ended March 31,
2007. Due to these and additional factors, the statements, historical
results and percentage relationships set forth herein are not necessarily
indicative of the results of operations for any future period. These
forward-looking statements are based on management's current beliefs and
expectations, some or all of which may prove to be inaccurate, and which
may change. We undertake no obligation to revise or update any
forward-looking statements to reflect any event or circumstance that may
arise after the date of this release.
For more information, please click here
3050 Zanker Road
San Jose, CA 95134
(408) 325-6444 Fax
Copyright © PR Newswire Association LLC.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Physicists explain the unusual behavior of strongly disordered superconductors: Using a theory they developed previously, the scientists have linked superconducting carrier density with the quantum properties of a substance November 25th, 2015
Strange quantum phenomenon achieved at room temperature in semiconductor wafers November 21st, 2015
MIT mathematicians identify limits to heat flow at the nanoscale: New formula identifies limits to nanoscale heat transfer, may help optimize devices that convert heat to electricity November 25th, 2015
Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015
Production of Nanocapsules Containing Omega-3 Powder in Iran November 24th, 2015
Using light-force to study single molecules November 23rd, 2015
Breakthrough allows tracking of single molecules in 3-D with nanoscale accuracy:New method builds on Nobel Prize-winning technique, with exciting implications for understanding the inner workings of cells and neurons November 23rd, 2015
UCLA nanoscientists develop safer, faster way to remove pollutants from water November 23rd, 2015
New EU project designed to link diagnosis and treatment of diseases over the long term: Joint research project aims at the improvement of companion diagnostics and therapy of tumor diseases November 23rd, 2015